An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1.

Isis B T JoostenCheyenne E W JanssenCorinne G C HorlingsDennis W den UijlReinder EvertzBaziel G M van EngelenCatharina G FaberKevin Vernooy

Published in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2022)

Twenty-four hour Holter monitoring is of added value to routine cardiac screening for all DM1 patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
early onset
heart failure
atrial fibrillation
muscular dystrophy
insulin resistance
patient reported